Investigational Chemotherapy Service — Durham, North Carolina

Investigational Chemotherapy Service is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Investigational Chemotherapy Service has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Non-small Cell Lung Cancer, Urothelial Cancer, Squamous Cell Carcinoma of the Head and Neck.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Chemotherapy Service?

Investigational Chemotherapy Service has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Chemotherapy Service conducted?

Investigational Chemotherapy Service has 5 clinical trials on record, with 2 currently active. Their work covers Non-small Cell Lung Cancer, Urothelial Cancer, Squamous Cell Carcinoma of the Head and Neck.

Is Investigational Chemotherapy Service accredited by Crixeo Health?

Investigational Chemotherapy Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Chemotherapy Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.